Although society has experimented with unorthodox methods of treating health problems for centuries, the business of complementary and alternative medicine (CAM) has grown and diversified dramatically over the past few decades. Despite the unconventional nature of CAM interventions, their extensive promotion through mainstream outlets blurs the lines between what is and is not scientifically accepted. For example, celebrity cardiologist Dr. Oz recently came under fire at a U.S. Senate hearing after encouraging viewers to take various products that he deemed “miracle” weight–loss cures, despite his awareness of their lack of scientific evidence. While it is hard not to be enticed by the promise of CAM, keeping a close eye on its evidence will be critical as the overlap between personalized and evidence–based medicine increases.
Between 29 % and 42 % of American adults have used some form of CAM in the previous year. In some samples of children living with cancer, the prevalence rates of CAM use are as high as 91 %. Despite the popularity of CAM treatments, we still know shockingly little about them. This is because CAM interventions are regulated completely separately from conventional medicine—and sometimes, they are not regulated at all. As a result, CAM interventions may be marketed and used without standing up to the same clinical tests of efficacy and safety as conventional medicine. Furthermore, testimonial reports, such as those from Dr. Oz, often form the basis of CAM marketing. In reviewing CAM websites, researchers have found various anecdote–based recommendations for therapies that have been scientifically shown not only to have little benefit, but to be potentially dangerous. Not bound by the same regulations as conventional medicine, CAM marketers may conveniently select compelling anecdotes that, despite holding no validity of measure, present hopeful messages to a desperate patient.
While some CAM trials appear to exhibit strong scientific rigour, many others are fraught with methodological shortcomings. One common drawback to clinical CAM research is a lack of comparison to a placebo—or control—group. The problem with relying solely on treatment group outcomes is the utter neglect of effects that could arise from not receiving the treatment, such as spontaneous improvement, regression to the mean (a natural tendency for initially extreme measurements to regress back to the group mean upon follow–up measurement), and the placebo effect (a physiological improvement arising from simply going through the motions of being “treated”). Unless we are able to measure baseline and post–treatment effects in both the treatment group and control group, there is no way to confirm that the benefits gained were actually due to the treatment itself. However, in cases where CAM randomized controlled trials (RCT) exist, study validity is still called into question. For example, a Lancet review stirred controversy between CAM and conventional medicine proponents  with its conclusion that, after controlling for biases in both CAM and conventional RCTs, there was only weak evidence for a specific effect of CAM therapies, while there was strong evidence in support of conventional therapies.
As more patients adopt an interest in CAM, its integration with conventional practice is becoming more common. For example, roughly 40 % of American mainstream physicians have referred patients for acupuncture and/or chiropractic therapies. These types of CAM treatments might appear more favourable to physicians due to their longer histories of scientific scrutiny, which have allowed them to be increasingly seen as accepted practices.[13-15] Physicians might also be integrating CAM into their practice in an effort to prevent the dangers associated with patients using it without their consultation. For example, despite decades of research showing the effectiveness of the popular herbal supplement, St. John’s wort, for treatment of some forms of depression,[16,17] patients taking this product without physician consultation run the risk of suffering potentially dangerous reactions due to the supplement’s ability to interact with a long list of conventional drugs.[18,19] It is becoming increasingly important for physicians to be aware of the evidence base surrounding different CAM options in order to develop a safe and effective treatment plan for their CAM–using patients. Evidently, there is a strong and ongoing need for rigorous scientific evidence to inform the use of CAM.
But if we apply the same evidence–based model for CAM, would we be moving past the point of CAM altogether? As science writer Michael Specter has so simply put it, “If we were to do that, there would really be nothing ‘complementary’ or ‘alternative’ about CAM.”
CAM approaches the healing process as a function of the “whole system,” rather than targeting a single physiological component. As such, CAM proponents argue that in applying conventional study design to unconventional interventions, we are diluting the true effect of the treatment by attempting to single out one component of the whole.[22-24] The deductive evidence–based model by which conventional medicine is accepted into practice (i.e., understanding the molecular biology of a therapy before moving on to various stages of clinical trials and eventual practice) stands in stark contrast to the inductive approach used for CAM (i.e., widespread use of a CAM therapy before evaluation through clinical trials and eventual understanding of its molecular biology). CAM researchers have suggested developing a separate, validated framework for the evaluation of CAM treatments, which would take into account the unique differences between the goals of CAM compared to those of conventional medicine. By recognizing the “whole system” as an essential philosophy of CAM, such a framework would aim to fill the gap that currently exists between the widespread positive anecdotal reports of CAM and the evidence that opposes these claims. Accordingly, comprehensive and high–quality CAM evidence should evaluate both individual components through RCTs and “whole–system” effects under real–world conditions (i.e. without manipulating other environmental and biological processes), while considering the patient perspective, the conceptual basis, and the medical professionalism of the therapy.
As we move into the era of individualized, integrated, and alternative medicine, we will have to decide what we are willing to accept as a “gold standard” for CAM, and whether this can stray from the pre–defined, single–outcome approach with which conventional practitioners are so comfortable. In the meantime, available, unbiased, and evidence–based resources for CAM, such as the Natural Medicines database, should be used by conventional practitioners and shared with patients. Safe and positive results could be possible with CAM, so long as we are able to set biases aside and to separate the evidence from the anecdote.
- Whorton JC. Conversations in complementary and alternative medicine: insights and perspectives from leading practitioners. Cella D, editor. Mississauga (ON): Jones and Bartlett Learning; c2006. Chapter 1, History of complementary and alternative medicine; p. 1-8.
- Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow–up national survey. J Amer Med Assoc. 1998 Nov 11;280(18):1569-75.
- Associated Press; Daily Mail Reporter. Dr. Oz skewered on Capitol Hill for advertising ‘miracle’ products — as he admits they ‘don’t pass scientific muster’. The Guardian. [Internet]. 2014 Jun 17. [updated 2014 Jun 18;cited 2015 May 3]. Available from: http://www.dailymail.co.uk/news/article-2660450/Dr-Oz-scolded-hearing-weight-loss-scams.html.
- Miller FG, Ezekiel JE, Rosenstein DL, Straus SE. Ethical issues concerning research in complementary and alternative medicine. J Amer Med Assoc. 2004 Feb 4;291(5):599-604.
- Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics. 2010 Mar 22;125(4):768-76.
- Vogel, L. ‘Hodge-podge’ regulation of alternative medicine in Canada. Can Med Assoc J. 2010 Sep 7;182(12):E569-70.
- Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Ann Oncol. 2004 May;15(5):733-42.
- Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol. 2001 Jun;30(3):526-31.
- Nahin RL, Straus SE. Research into complementary and alternative medicine: problems and potential. Brit Med J. 2001 Jan 20;322(7279):161-4.
- Rutten ALB, Stolper CF. The 2005 meta–analysis of homeopathy: the importance of post-publication data. Homeopathy. 2008 Oct;97(4):169-77.
- Shang A, Huwiler-Müntener K, Nartey L, Jüni P, Dörig S, Sterne JAC, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet. 2005 Aug 27;366(9487):726-32.
- Astin J, Marie A, Pelletier KR, Hansen E, Haskell WL. A review of the incorporation of complementary and alternative medicine by mainstream physicians. Arch Intern Med. 1998 Nov 23;158(23):2303-10.
- Meeker WC, Haldeman S. Chiropractic: a profession at the crossroads of mainstream and alternative medicine. Ann Intern Med. 2002 Feb 5;136(3):216-27.
- World Health Organization. Acupuncture: review and analysis of reports on controlled clinical trials. Geneva (Italy): World Health Organization; 1996, p. 5.
- Bell IR, Caspi O, Schwartz GE, Grant KL, Gaudet TW, Rychener D, et al. Integrative medicine and systemic outcomes research. Arch Intern Med. 2002 Jan 28;162:133-40.
- Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John’s wort for depression—an overview and meta–analysis of randomised clinical trials. Brit Med J. 1996 Aug 3;313(7052):253-8.
- Linde K, Berner MM, Kriston L. St John’s wort for major depression. Cochrane Database Syst Rev [Internet]. 2008 Oct 8 [cited 2015 May 3]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000448.pub3/abstract.
- Mills E, Montori VM, Wu P, Gallicano K, Clarke M, Guyatt G. Interaction of St John’s wort with conventional drugs: systematic review of clinical trials. Brit Med J. 2004 Jul 1;329(7456):27-30.
- Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. St John’s wort (Hypericum perforatum): drug interactions and clinical outcomes. Brit J Clin Pharmaco. 2002 Oct 23;54(4):349-56.
- Specter M. Denialism: how irrational thinking hinders scientific progress, harms the planet, and threatens our lives. New York: The Penguin Press; 2009. p. 158.
- Kienle GS, Albonico HU, Fischer L, Frei-Erb M, Hamre HJ, Heusser P, et al. Complementary therapy systems and their integrative evaluation. Explore-NY. 2011 May;7(3):175-87.
- Fonnebo V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H, et al. Researching complementary and alternative treatments—the gatekeepers are not at home. BMC Med Res Methodol. 2007 Feb 11;7:7.
- Verhoef MJ, Lewith G, Ritenbaugh C, Boon H, Fleishman S, Leis A. Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT. Complement Ther Med. 2005 Aug 15;13(3):206-12.
- Weatherley-Jones E, Thompson EA, Thomas KJ. The placebo–controlled trial as a test of complementary and alternative medicine: observations from research experience of individualised homeopathic treatment. Homeopathy. 2004 Oct;93(4):186-9.
- Therapeutic Research Center. Natural Medicines [Internet]. Somerville (MA): Therapeutic Research Center; 2015 [cited 2015 May 2]. Available from: https://naturalmedicines.therapeuticresearch.com/.
Lake S. Evidence–Based Medicine and the Growing Popularity of Complementary and Alternative Treatments. UBCMJ. 2015: 7.1 (40-41).